Add to ORKGIntroduction: Acute kidney injury (AKI) can evolve quickly and clinical measures of function often fail to detect AKI at a time when interventions are likely to provide benefit. Identifying early markers of kidney damage has been difficult due to the complex nature of human AKI, in which multiple etiologies exist. The objective of this study was to identify and validate novel biomarkers of AKI. Methods: We performed two multicenter observational studies in critically ill patients at risk for AKI- discovery an
RationaleWe recently reported two novel biomarkers for acute kidney injury (AKI), tissue inhibitor o...
In the past decades, the incidence of acute kidney dysfunction has been steadily increasing, which i...
Accompanied with the broad application of interventional therapy, the incidence of acute kidney inju...
Introduction: Acute kidney injury (AKI) can evolve quickly and clinical measures of function often f...
Abstract Introduction Acute kidney injury (AKI) can evolve quickly and clinical measures of function...
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injur
Introduction: Early recognition of patients developing acute kidney injury (AKI) is of considerable ...
Acute Kidney Injury (AKI) is common in critical illness, and contributes to high mortality. Current...
Acute Kidney Injury (AKI) is a prevalent systemic disorder that has an extremely high rate of mortal...
Acute kidney injury (AKI) affects many hospitalized patients and is associated with increased morbid...
The past 5-10 years have brought significant advances in the identification and validation of novel ...
textabstractAcute kidney injury (AKI) is strongly associated with increased morbidity and mortality ...
Over the last decade there has been considerable progress in the discovery and development of biomar...
Acute kidney injury (AKI) is strongly associated with increased morbidity and mortality in criticall...
Importance: In the last decade, new biomarkers for acute kidney injury (AKI) have been identified an...
RationaleWe recently reported two novel biomarkers for acute kidney injury (AKI), tissue inhibitor o...
In the past decades, the incidence of acute kidney dysfunction has been steadily increasing, which i...
Accompanied with the broad application of interventional therapy, the incidence of acute kidney inju...
Introduction: Acute kidney injury (AKI) can evolve quickly and clinical measures of function often f...
Abstract Introduction Acute kidney injury (AKI) can evolve quickly and clinical measures of function...
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injur
Introduction: Early recognition of patients developing acute kidney injury (AKI) is of considerable ...
Acute Kidney Injury (AKI) is common in critical illness, and contributes to high mortality. Current...
Acute Kidney Injury (AKI) is a prevalent systemic disorder that has an extremely high rate of mortal...
Acute kidney injury (AKI) affects many hospitalized patients and is associated with increased morbid...
The past 5-10 years have brought significant advances in the identification and validation of novel ...
textabstractAcute kidney injury (AKI) is strongly associated with increased morbidity and mortality ...
Over the last decade there has been considerable progress in the discovery and development of biomar...
Acute kidney injury (AKI) is strongly associated with increased morbidity and mortality in criticall...
Importance: In the last decade, new biomarkers for acute kidney injury (AKI) have been identified an...
RationaleWe recently reported two novel biomarkers for acute kidney injury (AKI), tissue inhibitor o...
In the past decades, the incidence of acute kidney dysfunction has been steadily increasing, which i...
Accompanied with the broad application of interventional therapy, the incidence of acute kidney inju...